RODNEY CLARK: Open Payments
NPI 1417443953 · DES MOINES, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$37,860 in 191 payments from 15 companies in 2025. Trend: 2023 $6,775 · 2024 $15,358 · 2025 $37,860
Speaker / faculty: $33,150Food & beverage: $3,360Travel & lodging: $1,150Education: $200
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 40 | $22,510 |
| Lilly USA, LLC | 25 | $12,241 |
| Janssen Biotech, Inc. | 32 | $923 |
| UCB, Inc. | 21 | $565 |
| ABBVIE INC. | 28 | $457 |
| Novartis Pharmaceuticals Corporation | 12 | $431 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 10 | $295 |
| GENZYME CORPORATION | 8 | $199 |
| Arcutis Biotherapeutics, Inc. | 2 | $55 |
| Organon LLC | 5 | $46 |
Products named: NEMLUVIO, EBGLYSS, TREMFYA, Bimzelx, SKYRIZI, Rhapsido, DUPIXENT, ILUMYA.
Industry payments across IA — which companies pay providers there.
